16-2053388-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001406680.1(TSC2):​c.-545C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000492 in 1,591,930 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00049 ( 3 hom. )

Consequence

TSC2
NM_001406680.1 5_prime_UTR_premature_start_codon_gain

Scores

4
9
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16O:2

Conservation

PhyloP100: 7.67

Publications

18 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0091893375).
BP6
Variant 16-2053388-C-T is Benign according to our data. Variant chr16-2053388-C-T is described in ClinVar as Benign. ClinVar VariationId is 49225.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 83 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001406680.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.272C>Tp.Pro91Leu
missense
Exon 4 of 42NP_000539.2P49815-1
TSC2
NM_001406680.1
c.-545C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 42NP_001393609.1
TSC2
NM_001406681.1
c.-174C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 40NP_001393610.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.272C>Tp.Pro91Leu
missense
Exon 4 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.272C>Tp.Pro91Leu
missense
Exon 4 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.272C>Tp.Pro91Leu
missense
Exon 4 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.000545
AC:
83
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000917
AC:
194
AN:
211654
AF XY:
0.000997
show subpopulations
Gnomad AFR exome
AF:
0.0000790
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0157
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000407
Gnomad OTH exome
AF:
0.00150
GnomAD4 exome
AF:
0.000487
AC:
701
AN:
1439708
Hom.:
3
Cov.:
31
AF XY:
0.000541
AC XY:
386
AN XY:
714100
show subpopulations
African (AFR)
AF:
0.0000302
AC:
1
AN:
33132
American (AMR)
AF:
0.00
AC:
0
AN:
41764
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
370
AN:
25654
East Asian (EAS)
AF:
0.0000259
AC:
1
AN:
38638
South Asian (SAS)
AF:
0.0000485
AC:
4
AN:
82544
European-Finnish (FIN)
AF:
0.0000197
AC:
1
AN:
50764
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5354
European-Non Finnish (NFE)
AF:
0.000233
AC:
257
AN:
1102382
Other (OTH)
AF:
0.00113
AC:
67
AN:
59476
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
46
92
137
183
229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000545
AC:
83
AN:
152222
Hom.:
0
Cov.:
33
AF XY:
0.000632
AC XY:
47
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68042
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000862
Hom.:
0
Bravo
AF:
0.000533
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.000932
AC:
8
ExAC
AF:
0.000492
AC:
59
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (6)
-
-
4
not provided (4)
-
-
4
Tuberous sclerosis 2 (4)
-
-
2
Tuberous sclerosis syndrome (3)
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.045
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.84
D
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0090
T
MetaSVM
Benign
-0.32
T
MutationAssessor
Benign
2.0
M
PhyloP100
7.7
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Uncertain
0.50
Sift
Uncertain
0.026
D
Sift4G
Uncertain
0.0070
D
Polyphen
1.0
D
Vest4
0.81
MVP
0.57
ClinPred
0.11
T
GERP RS
4.8
PromoterAI
-0.015
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.31
gMVP
0.56
Mutation Taster
=54/46
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45482691; hg19: chr16-2103389; COSMIC: COSV54773202; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.